申请人:Schering Aktiengesellschaft
公开号:US05880126A1
公开(公告)日:1999-03-09
9H-Pyrido\x9b3,4-b!indole compounds have a pronounced leukotriene-B.sub.4 antagonistic action, and thus show a completely different spectrum of activity than known .beta.-carbolines.
9H-Pyrido[3,4-b]吲哚化合物具有明显的白三烯B4拮抗作用,因此显示出与已知的β-咔唑啉完全不同的活性谱。